Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients
- PMID: 16448701
- DOI: 10.1016/j.jad.2005.12.029
Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients
Abstract
Background: Depression has been associated with low brain-derived neurotrophic factor (BDNF) serum levels, while antidepressant drugs appear to mend this alteration. The purpose of this study was to assess BDNF serum levels in drug resistant depressed patients before and after repetitive Transcranial Magnetic Stimulation (rTMS) antidepressant treatment.
Methods: BDNF levels were measured in serum of 16 resistant depressed patients using the ELISA technique.
Results: BDNF baseline levels showed a negative correlation with illness severity measured by HDRS scores (R = -0.517, p = 0.04) and a significant increase of serum BDNF was found after rTMS treatment (t = -2.549, df = 15, p = 0.022).
Conclusions: Our findings support the relationship between decreased serum BDNF and depression symptomatology and suggest a normalizing effect of rTMS antidepressant treatment. Further replications in larger samples will help to clarify the relevance of this preliminary data in the rTMS mechanism of action.
Similar articles
-
High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors.Pharmacopsychiatry. 2006 Mar;39(2):52-9. doi: 10.1055/s-2006-931542. Pharmacopsychiatry. 2006. PMID: 16555165
-
Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression: replication study in drug-free patients.J Affect Disord. 2008 May;108(1-2):59-70. doi: 10.1016/j.jad.2007.09.007. Epub 2007 Oct 26. J Affect Disord. 2008. PMID: 17963846
-
Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments.J Affect Disord. 2008 Jan;105(1-3):279-83. doi: 10.1016/j.jad.2007.05.005. Epub 2007 Jun 5. J Affect Disord. 2008. PMID: 17553570
-
[Major depressive disorders and BDNF (brain-derived neurotrophic factor)].Nihon Shinkei Seishin Yakurigaku Zasshi. 2004 Jun;24(3):147-50. Nihon Shinkei Seishin Yakurigaku Zasshi. 2004. PMID: 15291244 Review. Japanese.
-
Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies.Pharmacol Ther. 2008 Jan;117(1):30-51. doi: 10.1016/j.pharmthera.2007.07.001. Epub 2007 Aug 15. Pharmacol Ther. 2008. PMID: 17949819 Review.
Cited by
-
Biological markers in noninvasive brain stimulation trials in major depressive disorder: a systematic review.J ECT. 2014 Mar;30(1):47-61. doi: 10.1097/YCT.0b013e31828b34d8. J ECT. 2014. PMID: 23845938 Free PMC article. Review.
-
Repetitive transcranial magnetic stimulation as a potential treatment approach for cannabis use disorder.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jul 13;109:110290. doi: 10.1016/j.pnpbp.2021.110290. Epub 2021 Mar 4. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 33677045 Free PMC article. Review.
-
Protective Effects of Repetitive Transcranial Magnetic Stimulation Against Streptozotocin-Induced Alzheimer's Disease.Mol Neurobiol. 2024 Mar;61(3):1687-1703. doi: 10.1007/s12035-023-03573-8. Epub 2023 Sep 27. Mol Neurobiol. 2024. PMID: 37755583 Free PMC article.
-
Progress and challenges in preclinical stroke recovery research.Brain Circ. 2021 Dec 21;7(4):230-240. doi: 10.4103/bc.bc_33_21. eCollection 2021 Oct-Dec. Brain Circ. 2021. PMID: 35071838 Free PMC article. Review.
-
Association study of theta EEG asymmetry and brain-derived neurotrophic factor gene variants in childhood-onset mood disorder.Neuromolecular Med. 2008;10(4):343-55. doi: 10.1007/s12017-008-8038-x. Epub 2008 Jun 10. Neuromolecular Med. 2008. PMID: 18543122
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
